AndroGel Articles

Actavis wins generic Pulmicort Respules case; challenges AbbVie patent

2 April 2013

FTC seeks US Supreme Court review in AndroGel "pay-for-delay" case

8 October 2012

Profit plummets 55% for Solvay in recession

15 May 2009

Solvay's 2008 profit drops 46%, hit by losses on Fortis holdings and forex effects

2 March 2009

Solvay's 1st-qtr 2008 net income rises 1%

26 May 2008

Watson swings to profit of $38.4M in 4th qtr

3 March 2008

Solvay's 2007 income climbs just 1%

25 February 2008

Watson's 3rd-qtr 2007 revenue hits $594.7M

19 November 2007

Solvay submits US sNDA for AndroGel

25 June 2007

Watson's 1st-qtr 2007 income leaps 26%

14 May 2007

Watson sees a 4th-qtr 2006 net loss of $489M

12 March 2007

Solvay signs AndroGel expansion deal

27 March 2006

Solvay's 2005 revenue reaches 8.5 B euros

27 February 2006

ICOS and Solvay form AndroGel alliance

7 February 2005

Schering AG gets Euro Testogel rights

8 July 2002

Pretax profits down at Belgium's Solvay

18 February 2002

Unimed, TAP to copromote AndroGel

7 June 2001

Belgium's Solvay places emphasis on growing pharmaceuticals further

12 February 2001

Unimed files NDA for hypogonadism

16 July 1999

Solvay Group agrees to acquire Unimed Pharmaceuticals for $123 million

14 June 1999

Unimed files NDA for Androgel in USA

6 May 1999

Unimed Completes Enrollment For Ph III Androgel Trial

4 June 1998

Phase III Trials Of Androgel-DHT

18 September 1997

Unimed Begins Ph III With Androgel

7 April 1997

Unimed's Androgel For AIDS Wasting

8 July 1996

Unimed To Launch Androgel Trial

10 June 1996

FTC sues Watson and Par over AndroGel deal